Membrane interactions of designed cationic antimicrobial peptides: the two thresholds - PubMed (original) (raw)
Membrane interactions of designed cationic antimicrobial peptides: the two thresholds
Evgenia Glukhov et al. Biopolymers. 2008 May.
Abstract
Novel cationic antimicrobial peptides (CAPs) designed in our lab-typified by sequences such as KKKKKKAAX-AAXAAXAA-NH(2), where X = Phe/Trp-display high antibacterial activity but exhibit little or no hemolytic activity towards human red blood cells even at high doses. To clarify the mechanism of their selectivity for bacterial versus mammalian membranes and to increase our understanding of the relationships between primary sequence and bioactivity, a library of derivatives was prepared by increasing segmental hydrophobicity, in which systematic substitutions of Ala for two, three, or four Leu residues were made. Conformationally constrained dimeric and cyclic derivatives were also synthesized. The peptides were examined for activity against pathogenic bacteria (Pseudomonas aeruginosa), hemolytic activity on human red blood cells, and insertion into models of natural bacterial membranes (containing anionic lipids) and mammalian membranes (containing zwitterionic lipids + cholesterol). Results were compared with corresponding properties of the natural CAPs magainin and cecropin. Using circular dichroism and fluorescence spectroscopy, we found that peptide conformation and membrane insertion were sequence dependent, both upon the number of Leu residues, and upon their positions along the hydrophobic core. Membrane disruption was likely enhanced by the fact that the peptides contain potent dimerization-promoting sequence motifs, as assessed by SDS-PAGE gel analysis. The overall results led us to identify distinctions in the mechanism of actions of these CAPs for disruption of bacterial versus mammalian membranes, the latter dependent on surpassing a "second hydrophobicity threshold" for insertion into zwitterionic membranes.
Similar articles
- Sequence requirements and an optimization strategy for short antimicrobial peptides.
Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE. Hilpert K, et al. Chem Biol. 2006 Oct;13(10):1101-7. doi: 10.1016/j.chembiol.2006.08.014. Chem Biol. 2006. PMID: 17052614 - New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.
Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L. Cerovský V, et al. Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19. Peptides. 2008. PMID: 18375018 - Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
Zhu WL, Lan H, Park Y, Yang ST, Kim JI, Park IS, You HJ, Lee JS, Park YS, Kim Y, Hahm KS, Shin SY. Zhu WL, et al. Biochemistry. 2006 Oct 31;45(43):13007-17. doi: 10.1021/bi060487+. Biochemistry. 2006. PMID: 17059217 - Design and synthesis of antimicrobial peptides.
Merrifield RB, Merrifield EL, Juvvadi P, Andreu D, Boman HG. Merrifield RB, et al. Ciba Found Symp. 1994;186:5-20; discussion 20-6. Ciba Found Symp. 1994. PMID: 7768157 Review. - Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes?
Papo N, Shai Y. Papo N, et al. Peptides. 2003 Nov;24(11):1693-703. doi: 10.1016/j.peptides.2003.09.013. Peptides. 2003. PMID: 15019200 Review.
Cited by
- Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms.
Beaudoin T, Stone TA, Glibowicka M, Adams C, Yau Y, Ahmadi S, Bear CE, Grasemann H, Waters V, Deber CM. Beaudoin T, et al. Sci Rep. 2018 Oct 3;8(1):14728. doi: 10.1038/s41598-018-33016-7. Sci Rep. 2018. PMID: 30283025 Free PMC article. - Contribution of Amphipathicity and Hydrophobicity to the Antimicrobial Activity and Cytotoxicity of β-Hairpin Peptides.
Edwards IA, Elliott AG, Kavanagh AM, Zuegg J, Blaskovich MA, Cooper MA. Edwards IA, et al. ACS Infect Dis. 2016 Jun 10;2(6):442-450. doi: 10.1021/acsinfecdis.6b00045. Epub 2016 Apr 29. ACS Infect Dis. 2016. PMID: 27331141 Free PMC article. - Evolving and assembling to pierce through: Evolutionary and structural aspects of antimicrobial peptides.
Chakraborty S, Chatterjee R, Chakravortty D. Chakraborty S, et al. Comput Struct Biotechnol J. 2022 May 10;20:2247-2258. doi: 10.1016/j.csbj.2022.05.002. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 35615024 Free PMC article. Review. - Expression and characterization of the new antimicrobial peptide AP138L-arg26 anti Staphylococcus aureus.
Zhang K, Yang N, Teng D, Mao R, Hao Y, Wang J. Zhang K, et al. Appl Microbiol Biotechnol. 2024 Dec;108(1):111. doi: 10.1007/s00253-023-12947-w. Epub 2024 Jan 13. Appl Microbiol Biotechnol. 2024. PMID: 38229298 Free PMC article. - Peptide/Peptoid Hybrid Oligomers: The Influence of Hydrophobicity and Relative Side-Chain Length on Antibacterial Activity and Cell Selectivity.
Frederiksen N, Hansen PR, Björkling F, Franzyk H. Frederiksen N, et al. Molecules. 2019 Dec 4;24(24):4429. doi: 10.3390/molecules24244429. Molecules. 2019. PMID: 31817108 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous